Assessment of Fall-Related Self-Efficacy: Characteristics that Influence the Perception of Patients with Chemotherapy-Induced Peripheral Neuropathy

Assessment of Fall-Related Self-Efficacy: Characteristics that Influence the Perception of Patients with Chemotherapy-Induced Peripheral Neuropathy

Objective: The present study aims to describe fall-related self-efficacy as perceived by patients with chemotherapy-induced peripheral neuropathy (CIPN). The characteristics of patients associated with low perceived self-efficacy of preventing falls were investigated. Methods: A cross-sectional stud...

Full description

Bibliographic Details
Main Authors:	Sena Yamamoto, Naomi Fujikawa, Kota Asano, Masayo Toki, Ayumi Takao, Harue Arao
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Asia-Pacific Journal of Oncology Nursing
Subjects:	adverse effects ambulatory care chemotherapy fall peripheral neuropathy
Online Access:	http://www.apjon.org/article.asp?issn=2347-5625;year=2020;volume=7;issue=2;spage=190;epage=195;aulast=Yamamoto

Similar Items

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Exercise intervention for the management of chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis
by: Natsuki Nakagawa, et al.
Published: (2024-01-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Extended effects of a wearable sensory prosthesis on gait, balance function and falls after 26 weeks of use in persons with peripheral neuropathy and high fall risk—The walk2Wellness trial
by: Lars I. E. Oddsson, et al.
Published: (2022-09-01)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
by: Takehiro Kawashiri, et al.
Published: (2021-01-01)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
by: Takehiro Kawashiri, et al.
Published: (2021-08-01)

Effect of hypertension on diabetic peripheral neuropathy
by: Ihsan M. Ajeena
Published: (2008-07-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Gender differences in Diabetic Peripheral Neuropathy
by: Mona Abosrea, et al.
Published: (2020-01-01)

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
by: Jamie Burgess, et al.
Published: (2021-01-01)

Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)

Sensory-Motor Mechanisms Increasing Falls Risk in Diabetic Peripheral Neuropathy
by: Neil D. Reeves, et al.
Published: (2021-05-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Focal Peripheral Neuropathies (4th ed)
by: Colin Chalk
Published: (2010-10-01)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
by: Bojana Milutinovic, et al.
Published: (2022-07-01)

Peripheral Nerve Block in Patients with Diabetic Peripheral Neuropathy
by: WANG Jia
Published: (2022-11-01)

Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
by: Kohei Mori, et al.
Published: (2022-11-01)

Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
by: Preston FG, et al.
Published: (2023-06-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
by: Katarzyna Szklener, et al.
Published: (2022-01-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
by: Yuping Mo, et al.
Published: (2022-09-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Leflunomide-Induced Peripheral Neuropathy in a Patient with Rheumatoid Arthritis
by: Saliha EROGLU DEMIR, et al.
Published: (2014-06-01)

Role of high-resolution ultrasonography in the evaluation of the tibial and median nerves in diabetic peripheral neuropathy
by: Ranjan Tanu, et al.
Published: (2022-10-01)

A study on prevalence of diabetic peripheral neuropathy in diabetic patients attending a rural health and training centre
by: K Karthiksaravanan, et al.
Published: (2024-01-01)

Insulinoma with peripheral neuropathy: a case report
by: Marco Aurélio Vinhosa Bastos, et al.
Published: (2023-06-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)

Neuromodulation Therapy for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review
by: Ryan S. D’Souza, et al.
Published: (2022-08-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

The Efficacy of Neuromodulation Interventions for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
by: Xu R, et al.
Published: (2024-04-01)

Prevalence and risk factors of peripheral neuropathy in parkinson's disease
by: Aparna Ramachandran, et al.
Published: (2022-01-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Amyloid Proteins and Peripheral Neuropathy
by: Mohammed M. H. Albariqi, et al.
Published: (2020-06-01)